Cited by 199Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchGenetic Associations and Epidemiology

The DOI matches its Crossref record; 78 of the 79 references it cites were found in a registry or an index.

Large Meta-Analysis Establishes the ACE Insertion-Deletion Polymorphism as a Marker of Alzheimer's Disease

Open access

Lehmann, Donald J., Cortina-Borja, Mario, Warden, Donald R., Smith, A. David, Sleegers, Kristel, Prince, Jonathan A., van Duijn, Cornelia M., Kehoe, Patrick G.·2005·American Journal of Epidemiology

DOI 10.1093/aje/kwi202

Open this paper in CoChat — free account

Abstract

Apolipoprotein E epsilon4 (APOE*4) is the only fully established susceptibility allele for Alzheimer's disease. One of the most studied candidates is the insertion (I)/deletion (D) polymorphism (indel) of the gene for angiotensin I-converting enzyme (ACE). This study aimed to clarify its association with Alzheimer's disease. The meta-analysis included 39 samples, comprising 6,037 cases of Alzheimer's disease and 12,099 controls, using mainly primary data. Potential interactions with gender, age, ethnic group, and carrier status of the apolipoprotein E epsilon4 allele were all examined. D homozygotes were at reduced risk of Alzheimer's disease (odds ratio = 0.81, 95% confidence interval: 0.72, 0.90; corrected p = 0.0004); I homozygotes showed no association with Alzheimer's disease, while heterozygotes were at increased risk. Although there were clear differences among the three ethnic groups examined (North Europeans, South Caucasians, and East Asians), in all groups D homozygotes were at reduced risk. These results confirm the association of the angiotensin I-converting enzyme indel with Alzheimer's disease across diverse populations, although this is probably due to linkage disequilibrium with the true risk factor. Further, in North Europeans, both association and Hardy-Weinberg analysis suggested partial heterosis, that is, an increased risk for heterozygotes, due to a hidden interaction with another, as yet unknown, risk factor. This interaction warrants further investigation.

Integrity signals

Registry

Crossref · 10.1093/aje/kwi202

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Gentleman R: R: A language for data analysis and graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,747
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Elsevier eBooks · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,168
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499

Show all 79 references

Research works printed but not linked: 1

Armitage P. Statistical methods in medical research. Oxford, United Kingdom: Blackwell Scientific Publications, 1983.

Sorted by citations

Items 101–199 of 199

Association of ACE I/D Gene Polymorphism With Vascular Dementia: A Meta-Analysis
Liu, H., Liu, M., Li, W., Wu, B., Zhang, S., Fang, Y., & Wang, Y. (2008) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988708328221 · Cited by 19
The ACE Gene Is Associated with Late-Life Major Depression and Age at Dementia Onset in a Population-Based Cohort
Zettergren, A., Kern, S., Gustafson, D., Gudmundsson, P., Sigström, R., Östling, S., Eriksson, E., Zetterberg, H., Blennow, K., & Skoog, I. G. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.06.009 · Cited by 19
Gene expression alterations in Rocky Mountain elk infected with chronic wasting disease
Basu, U., Almeida, L. M., Dudas, S., Graham, C., Czub, S., Moore, S. S., & Guan, L. L. (2012) · Prion · doi:10.4161/pri.19915 · Cited by 18
The D-allele of ACE insertion/deletion polymorphism is associated with regional white matter volume changes and cognitive impairment in remitted geriatric depression
Hou, Z., Yuan, Y., Zhang, Z., Hou, G., You, J., & Bai, F. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.05.076 · Cited by 17
Associations of Angiotensin Converting Enzyme-1 and Angiotensin II Blood Levels and Cognitive Function
Yaşar, S., Varma, V. R., Harris, G. C., & Carlson, M. C. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170944 · Cited by 17
Insulin Resistance and Alzheimer’s Disease
Min, S., Joon, H. S., & Mook‐Jung, I. (2011) · InTech eBooks · doi:10.5772/23409 · Cited by 17
Susceptibility groups for Alzheimer's disease (OPTIMA cohort): Integration of gene variants and biochemical factors
Corder, E. H., & Beaumont, H. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.014 · Cited by 17
Association between ACE polymorphism, cognitive phenotype and APOE E4 allele in a Tunisian population with Alzheimer disease
Achouri-Rassas, A., Ali, N., Cherif, A., Fray, S., Siala, H., Zakraoui, N. O., Fredj, S. H., Kechaou, M., Anane, N., Slim, E., et al. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1468-3 · Cited by 16
Angiotensin-converting enzyme gene and plasma protein level in Alzheimer's disease in Taiwanese
Yang, Y., Lai, C.-L., Tyan, Y., Chou, M., Wang, L., Yang, M., & Liu, C.-K. (2011) · Age and Ageing · doi:10.1093/ageing/afq179 · Cited by 16
Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia
de Oliveira, F. F., Berretta, J. M., de Almeida, G. V., de Almeida, S. S., Chen, E., Smith, M. D. A. C., & Bertolucci, P. H. F. (2019) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1209_17 · Cited by 16
ACE2 and COVID-19: using Antihypertensive Medications and Pharmacogenetic Considerations
Snyder, E. M., & Johnson, B. D. (2020) · Pharmacogenomics · doi:10.2217/pgs-2020-0048 · Cited by 16
Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Is Not a Major Determining Factor in the Development of Sporadic Alzheimer Disease: Evidence from an Updated Meta-Analysis
Wang, X.-B., Cui, N.-H., Yang, J., Qiu, X.-P., Gao, J.-J., Yang, N., & Zheng, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111406 · Cited by 15
Association of insertion–deletion polymorphism of ACE gene and Alzheimer’s disease in Egyptian patients
Hassanin, O. M., Moustafa, M., & El-Masry, T. M. (2014) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2014.06.001 · Cited by 15
The effects of enhancing angiotensin converting enzyme in myelomonocytes on ameliorating Alzheimer’s-related disease and preserving cognition
Danziger, R., Fuchs, D.-T., Koronyo, Y., Rentsendorj, A., Sheyn, J., Hayden, E. Y., Teplow, D. B., Black, K. L., Fuchs, S., Bernstein, K. E., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1179315 · Cited by 16
Sarcopenia as a Risk Factor for Alzheimer’s Disease: Genetic and Epigenetic Perspectives
Raleigh, S. M., & Orchard, K. J. A. (2024) · Genes · doi:10.3390/genes15050561 · Cited by 14
Association between an angiotensin-converting enzyme gene polymorphism and Alzheimer’s disease in a Tunisian population
Fekih‐Mrissa, N., Bedoui, I., Sayeh, A., Derbali, H., Mrad, M., Mrissa, R., & Nsiri, B. (2017) · Annals of General Psychiatry · doi:10.1186/s12991-017-0164-0 · Cited by 14
Gene Expression in the Medulla Following Oral Infection of Cattle with Bovine Spongiform Encephalopathy
Almeida, L. M., Basu, U., Khaniya, B., Taniguchi, M., Williams, J. L., Moore, S. S., & Guan, L. L. (2011) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2011.529061 · Cited by 14
Haplotypes Across ACE and the Risk of Alzheimer's Disease: The Three-City Study
Bruandet, A., Richard, F., Tzourio, C., Berr, C., Dartigues, J., Alpérovitch, A., Amouyel, P., & Helbecque, N. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13310 · Cited by 19
N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer’s disease
Kugaevskaya, E. V., Veselovsky, A., Indeykina, M., Solovyeva, N. I., Zharkova, M. S., Popov, I., Nikolaev, E., Mantsyzov, A., Makarov, A., & Kozin, S. (2018) · Scientific Reports · doi:10.1038/s41598-017-18567-5 · Cited by 14
Angiotensin-converting enzyme polymorphisms AND Alzheimer’s disease susceptibility: An updated meta-analysis
Xin, X., Lai, Z.-H., Ding, K.-Q., Zeng, L., & Ma, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260498 · Cited by 15
APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study
Keage, H. A. D., Matthews, F. E., Yip, A. G., Gao, L., McCracken, C., McKeith, I. G., Rubinsztein, D. C., Brayne, C., & Study, M. C. F. A. A. (2009) · Age and Ageing · doi:10.1093/ageing/afp210 · Cited by 13
Precision medicine in trauma: a transformational frontier in patient care, education, and research
Davis, C. S., Wilkinson, K. H., Lin, E., Carpenter, N. J., Georgeades, C., Lomberk, G. A., & Urrutia, R. A. (2021) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-021-01817-7 · Cited by 11
Effects of Blood Pressure Changes on Alzheimer’s Disease
Feldstein, C. A. (2010) · Neuroepidemiology · doi:10.1159/000316872 · Cited by 12
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues
Torsello, A., Bresciani, E., Ravelli, M., Rizzi, L., Bulgarelli, I., Ricci, G., Ghiazza, B., Puppo, M. D., Mainini, V., Omeljaniuk, R. J., et al. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.06.006 · Cited by 12
Angiotensin-Converting Enzyme Gene in Alzheimer's Disease
Yang, Y., & Liu, C. (2008) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.215.295 · Cited by 12
Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases
Saibeni, S., Spina, L., Virgilio, T., Folcioni, A., Borsi, G., de Franchis, R., Cugno, M., & Vecchi, M. L. (2007) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282efa3fc · Cited by 11
More evidence for widespread antagonistic pleiotropy in polymorphic disease alleles
Lockwood, C., Vo, A. S., Bellafard, H., & Carter, A. J. R. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1404516 · Cited by 13
Deciphering mechanisms of action of ACE inhibitors in neurodegeneration using Drosophila models of Alzheimer’s disease
Ghalayini, J., & Boulianne, G. L. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1166973 · Cited by 10
Development of Wild Boar Species-Specific DNA Markers for a Potential Quality Control and Traceability Method in Meat Products
Szemethy, D., Mihalik, B., Frank, K., Nagy, T., Újváry, D., Kusza, S., Szemethy, L., Barta, E., & Stéger, V. (2020) · Food Analytical Methods · doi:10.1007/s12161-020-01840-1 · Cited by 10
Contributions of a Risk Assessment Approach to the Prevention of Alzheimer's Disease and Dementia
Anstey, K. J., Eramudugolla, R., & Dixon, R. A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141248 · Cited by 10
Boosting angiotensin-converting enzyme (ACE) in microglia protects against Alzheimer’s disease in 5xFAD mice
Gomez, A. R., Byun, H. R., Wu, S., Muhammad, A. K. M. G., Ikbariyeh, J., Chen, J., Muro, A., Li, L., Bernstein, K. E., Ainsworth, R., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00879-1 · Cited by 13
Presenilin-2 polymorphisms and risk of sporadic AD: Evidence from a meta-analysis
Chen, C., Zhou, Z., Li, M., Qu, M., Ma, Q., Zhong, M., Zhang, Y., & Yu, Z. (2012) · Gene · doi:10.1016/j.gene.2012.05.005 · Cited by 9
Divergence in the activity of the N- and C- catalytic domains of ACE1 - implications for the role of the renin-angiotensin system in Alzheimer’s disease
Mulhim, N. A., Kehoe, P. G., & Miners, J. S. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0718-2 · Cited by 8
Self-citation
Angiotensin-converting enzyme gene insertion-deletion polymorphism is a risk marker for Alzheimer’s disease in a Chinese population: a meta-analysis of case–control studies
Yuan, Y., Piao, J., Ma, K., & Lu, N. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1368-6 · Cited by 9
Meta-Analysis of Association Between Insertion/Deletion Polymorphism of the Angiotensin I-Converting Enzyme Gene and Venous Thromboembolism
Hsiao, F., & Hsu, L. (2009) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029609349499 · Cited by 9
Angiotensin-converting enzyme gene polymorphisms and risk for sporadic Alzheimer’s disease: a meta-analysis
Wang, X., Cui, N., Gao, J.-J., Qiu, X., Yang, N., & Zheng, F. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1235-x · Cited by 8
Brain-derived Neurotrophic Factor Genetic Variants are Associated with Major Depression Susceptibility and Serotonin Reuptake Inhibitor Antidepressant Treatment Response in Taiwanese
Liou, Y., Chen, T., Cheng, C., Yu, Y. W., Hong, C., & Tsai, S. (2014) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/1875692111666131211235804 · Cited by 8
Angiotensin converting enzyme and Alzheimer’s disease
Kugaevskaya, E. V. (2012) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s199075081201009x · Cited by 8
Angiotensin converting enzyme and Alzheimer's disease
Kugaevskaya, E. V. (2013) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20135901005 · Cited by 8
Genome-Wide Scan for Quantitative ACE Activity in Taiwan Young-Onset Hypertension Study
Wang, R.-Y., Chung, C., Fann, C. S. J., Yang, H., Chen, J., Jong, Y.-S., Jou, Y., Lo, H., Ho, F., Kang, C.-S., et al. (2007) · Human Heredity · doi:10.1159/000108940 · Cited by 8
Public health genomics – Relevance of genomics for individual health information management, health policy development and effective health services
Brand, A. M., & Brand, H. (2006) · Italian Journal of Public Health · doi:10.2427/5914 · Cited by 8
InTACT: An adaptive and powerful framework for joint‐tissue transcriptome‐wide association studies
Bae, Y. E., Wu, L., & Wu, C. (2021) · Genetic Epidemiology · doi:10.1002/gepi.22425 · Cited by 6
Losartan to slow the progression of mild-to-moderate Alzheimer’s disease through angiotensin targeting: the RADAR RCT
Kehoe, P. G., Turner, N. L., Howden, B., Jarutyt, L., Clegg, S., Malone, I. B., Barnes, J., Nielsen, C. F., Sudre, C. H., Wilson, A., et al. (2021) · Efficacy and Mechanism Evaluation · doi:10.3310/eme08190 · Cited by 7
Self-citation
Angiotensin II does not directly affect Aβ secretion or β-/γ-secretase activity via activation of angiotensin II type 1 receptor
Wang, B., Shi, J., Zhang, Y., Zhu, D., & Shi, J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.06.014 · Cited by 7
Medical genetics-based drug repurposing for Alzheimer's disease
Zhang, X., Quan, Y., & Tang, G.-Y. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.11.003 · Cited by 7
Association between the ACE gene I/D polymorphism and osteoporosis in a Turkish population
Çakmak, B., İnanır, A., Karakuş, N., Ateş, Ö., & Yığıt, S. (2015) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-015-1582-5 · Cited by 7
Association between dementia and vascular disease-associated polymorphisms in a Tunisian population
Hamdouni, H., Achour, O., Salma, N., Rejeb, J., Mariam, A., Mariem, M., Mariem, N., Rejeb, N. B., Asma, O., Sana, B. A., et al. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1348353 · Cited by 7
The Impact of Angiotensin-Converting Enzyme Gene on Behavioral and Psychological Symptoms of Dementia in Alzheimer’s Disease
Hsieh, S., Liu, M., Huang, L., Wu, M., & Yang, Y. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200103114550 · Cited by 7
Differences in allele frequencies of ACE I/D polymorphism between Northern and Southern Europe at different ages
Panza, F., Capurso, C. A., D’Introno, A., Colacicco, A. M., Kehoe, P. G., Seripa, D., Pilotto, A., Capurso, A., & Solfrizzi, V. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.040 · Cited by 7
Self-citation
Association of Increased Serum ACE Activity with Logical Memory Ability in Type 2 Diabetic Patients with Mild Cognitive Impairment
Tian, S., Han, J., Huang, R., Xia, W., Sun, J. L., Cai, R., Dong, X., Shen, Y., & Wang, S. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00239 · Cited by 6
Artificial Intelligence-Assisted Meta-Analysis of the Frequency of ACE I/D Polymorphisms in Centenarians and Other Long-Lived Individuals
Li, L., & Murakami, S. (2022) · medRxiv · doi:10.3390/ijms24043411 · Cited by 5
West African Mud Granaries
Prussin, L. (1972) · Paideuma · Cited by 6
ACE I/D polymorphism in Alzheimer’s disease
Trebuňová, M., Slabá, E., Habalová, V., & Gdovinová, Z. (2008) · Open Life Sciences · doi:10.2478/s11535-007-0051-9 · Cited by 5
Genetics of ischemic stroke: Inheritance of a sporadic disorder
Ross, O. A., & Meschia, J. F. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0004-y · Cited by 5
Genetic clues to the etiology of Balkan endemic nephropathy: Investigating the role of ACE and AT1R polymorphisms
Krcunovic, Z., Novaković, I. V., Maksimović, N., Bukvić, D., Simić‐Ogrizović, S., Janković, S., Djukanović, L., & Cvetković, D. (2010) · Archives of Biological Sciences · doi:10.2298/abs1004957k · Cited by 4
Cautions of Using Allele-Based Tests Under Heterosis
Omolo, B., Zhang, H., & Karmaus, W. (2013) · International Journal of Statistics in Medical Research · doi:10.6000/1929-6029.2013.02.01.06 · Cited by 4
Structure and physiological importance of angiotensin converting enzyme domains
Eliseeva, Y. E., & Kugaevskaya, E. V. (2009) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750809030032 · Cited by 4
Association study of MICA and MICB in Alzheimer’s disease
Quiroga, I., Lehmann, D. J., Barnardo, M., Fuggle, S., Cortina‐Borja, M., Warden, D. R., & Smith, A. D. (2009) · Tissue Antigens · doi:10.1111/j.1399-0039.2009.01297.x · Cited by 4
Self-citation
Association of Angiotensin-Converting Enzyme gene polymorphism and Alzheimer's risk in Kashmiri population
Nissar, K., Rauf, I., Hussain, A., Shah, P. A., & Ganai, B. A. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101309 · Cited by 4
Presenilin 1 deficiency impairs Aβ42-to-Aβ40- and angiotensin-converting activities of ACE
Gao, Y., Sun, Y., Islam, S., Nakamura, T., Tomita, T., Zou, K., & Michikawa, M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1098034 · Cited by 4
Renin-angiotensin system gene polymorphism and aging
Bebyakova, N. A., Levitsky, S. N., Алексеевна, Ш. И., Komandresova, T. M., & Kudryavtsev, A. V. (2023) · Экология человека · doi:10.17816/humeco516580 · Cited by 3
Blood type gene locus has no influence on ACE association with Alzheimer's disease
Braae, A., Medway, C., Carrasquillo, M. M., Younkin, S. G., Kehoe, P. G., & Morgan, K. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.01.013 · Cited by 3
Self-citation
Genetics of Vascular Dementia.
Murray, M. E., Meschia, J. F., Dickson, D. W., & Ross, O. A. (2010) · PubMed · Cited by 3
Association between ACE gene polymorphisms and Alzheimer's disease in Han population in Hebei Peninsula.
Wang, X., Zhang, F., Cui, Y., Zheng, L., & Yan, W. (2017) · PubMed Central · Cited by 3
A universal algorithm for de novo decrypting of heterozygous indel sequences: A tool for personalized medicine
Lam, C. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.11.011 · Cited by 2
acn-1, aC. eleganshomologue ofACE, genetically interacts with thelet-7microRNA and other heterochronic genes
Metheetrairut, C., Ahuja, Y., & Slack, F. J. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1344798 · Cited by 2
Sherlock Holmes and the empty cab
Weiss, K. M. (2006) · Evolutionary Anthropology Issues News and Reviews · doi:10.1002/evan.20116 · Cited by 2
Faculty Opinions recommendation of Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
Yan, R. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735170868.793558625 · Cited by 2
Angiotensin Converting Enzyme (ACE) expression in microglia reduces amyloid β deposition and neurodegeneration by increasing SYK signaling and endolysosomal traffickingPreprint
Gomez, A. R., Byun, H. R., Wu, S., Muhammad, A. G., Ikbariyeh, J., Chen, J., Muro, A., Li, L., Bernstein, K. E., Ainsworth, R. I., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.24.590837 · Cited by 2
Lack of association between two ACE gene polymorphisms (rs4291 and Alu I/D) and late onset Alzheimer's disease
Yenki, P., Safari, Z., & Azimi, C. (2012) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb11.3399 · Cited by 1
Genetic Risk Factors for Longitudinal Changes in Structural MRI in Former Organolead Workers
James, B. D., Caffo, B. S., Stewart, W. F., Yousem, D. M., Davatzikos, C. A., & Schwartz, B. S. (2011) · Journal of Aging Research · doi:10.4061/2011/362189 · Cited by 2
Seeking for associations of I/D polymorphism of ACE gene with self-reported work performance, memory, and cardiovascular health in a professional leadership community
Vlasov, A. V., Богданенко, Е. В., Kuzmina, L. P., & Yolov, А. А. (2024) · Russian Journal of Occupational Health and Industrial Ecology · doi:10.31089/1026-9428-2024-64-2-91-98 · Cited by 1
Is the Role of the Angiotensin-Converting Enzyme Gene in Alzheimer's Disease Independent of Hypertension?
Yang, Y., Yang, Y., Wu, S.-J., Huang, C., Fuh, J., Liu, C., Wu, S.-J., Huang, C., Fuh, J., & Liu, C. (2017) · Translational Neuroscience and Clinics · doi:10.18679/cn11-6030/r.2017.013 · Cited by 1
Pharmarcogenetic Mechanism of ACE I/D Polymorphism Adversely Responding to ACE Inhibitors in Regulating the ACE Promoter Activity in Neurons
Yang, Y.-H., Chang, H., Chang, W., Shih, Y.-C., Tsai, K.-L., Chien, I., & Wu, S.-J. (2016) · Journal of Pharmacy and Pharmacology · doi:10.17265/2328-2150/2016.08.010 · Cited by 1
Predictive Genetic Testing in Multifactorial Disorders
Hostiuc, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813764-2.00011-8 · Cited by 1
Genomics and proteomics are changing discovery, development and clinical use of dementia drugs
Mucke, H. A. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.3.313 · Cited by 1
Modulation der neutralen Endopeptidase im humanen Zellkultursystem durch pflanzliche Drogenextrakte und Naturstoffe
Ayoub, S. (2007) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-9327 · Cited by 1
Artificial intelligence-assisted meta-analysis of the frequency of ACE I/D polymorphisms in centenarians and other long-lived individualsPreprint
Li, L., & Murakami, S. (2022) · medRxiv · doi:10.1101/2022.12.10.22283306 · Cited by 1
Biomoleculaire dans van leven, ziekte en dood
Noteborn, M. H. M. (2005) · Leiden Repository (Leiden University)
Genetic Determinants of Cognitive Function and Age-Related Brain Changes
Schuur, M. (2010) · RePub (Erasmus University Rotterdam)
Human Longevity: Nature versus Nurture, Survival versus Mortality~!2010-04-29~!2010-06-30~!2010-08-31~!
Bowirrat, A. (2010) · The Open Complementary Medicine Journal · doi:10.2174/1876391x01002010090
with Achilles tendinopathy in two populations gene are associated COL5A1 Variants within the
September, A. V., Cook, J., Handley, C. J., van der Merwe, L., & Schwellnus, M. P. (2009)
Proteases In Β-Amyloid Metabolism: Potential Therapeutic Targets Against Alzheimer‘;S Disease
Brakch, N., & Rholam, M. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195326697.003.0016
Association between the ACE gene I/D polymorphism and osteoporosis in a Turkish population
Müller‐Ladner, U. (2015)
Genetic Determinants of Carbohydrate Consumption
Eny, K. M. (2010) · TSpace (University of Toronto)
Genetic Risk Factors for Complex Forms of Alzheimer’s Disease
Bellenguez, C., & Lambert, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_4
Use of Angiotensin II Receptor Blockers, Angiotensin I-Converting Enzyme Polymorphism and Associations with Memory Performance in Older People
Oscanoa, T. J., Cieza-Macedo, E. C., Grimaldo, O. E., Andia, Y. B., Lizaraso-Soto, F., Guevara, M. L., Fujita, R., & Romero‐Ortuño, R. (2021) · Advances in Gerontology · doi:10.1134/s2079057021020107
Genetic conditionality of strength by the ACE gene in women horse ridersPreprint
Majchrowicz, L., Matłosz, P., & Majchrowicz, R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.12.945444
P1–291: Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity
Sorbi, S. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.668
Human Genome & Diseases: Review The human genome and understanding of common disease: present and future technologies
McKinney, C., & Merriman, T. R. (2007)
Predictive genetic testing in multifactorial disorders
Hostiuc, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19045-2.00012-x
Angiotensin-converting enzyme inhibition and Alzheimer’s disease: Findings from proteome-wide Mendelian randomization and a large prospective cohort studyPreprint
Huang, P., Tang, H., Feng, Z., Stergiakouli, E., Gaunt, T. R., Zheng, J., & Lu, Y. (2024) · medRxiv · doi:10.1101/2024.09.09.24313366
The Contribution of the Renin-Angiotensin System to Alzheimer’s Disease
Güzel, Ö., & Kehoe, P. G. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_525
Self-citation
Additional file 1 of Multi-trait association studies discover pleiotropic loci between Alzheimer’s disease and cardiometabolic traits
Bone, W. P., Siewert, K. M., Jha, A., Klarin, D. M., Damrauer, S. M., Chang, K.-M., Tsao, P. S., Assimes, T. L., Ritchie, M. D., & Voight, B. F. (2021) · Figshare · doi:10.6084/m9.figshare.13719193
Systemic Amyloid-β Metabolism in Alzheimer’s Disease
Dong-yu, F., Wang, J., Gu, B. J., Masters, C. L., & Wang, Y. (2026) · Springer eBooks · doi:10.1007/978-981-95-5222-1_7
Recherche de facteurs associés à la maladie d’Alzheimer par réutilisation de base de données massives
Rochoy, M. (2019) · theses.fr (ABES) · doi:10.70675/4560bf49z9fd2z42a9z83e6zdd4b8e4e87ea
Gene therapy in Alzheimer’s disease (AD)
Bemanalizadeh, M., Ashrafi, M., Eslami, M., Moein, S., Kazemi, A., & Mansouri, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40467-2.00014-2
Plasma Angiotensin‐Converting Enzyme as a Prioritized Candidate Target for Alzheimer's Disease: Evidence From Proteome‐Wide Mendelian Randomization and a Large Prospective Cohort Study
Huang, P., Tang, H., Feng, Z., Stergiakouli, E., Gaunt, T. R., Zheng, J., & Lu, Y. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.124.038766
Assessment Of The Semantic Knowledge Network In Older Adults With Familial History Of Alzheimer's Disease
Holcomb, E. M. (2013) · Human Biology

Authors: Lehmann, D. J., Cortina-Borja, M., Warden, D. R., Smith, A. D., Sleegers, K., Prince, J. A., van Duijn, C. M., & Kehoe, P. G.
Affiliations: University of Oxford (GB)
Corresponding author: Lehmann, Donald J.
ORCID: Smith, A. David
Sleegers, Kristel
Kehoe, Patrick G.
Venue: American Journal of Epidemiology
Publisher: Oxford University Press (OUP)
Published: 2005-08-15
Volume: 162
Issue: 4
Pages: 305-317
ISSN: 0002-9262 (ISSN-L)
1476-6256
DOI: 10.1093/aje/kwi202
OpenAlex: W2044936845
Cited by: 199
References: 79
Citations by year: 2026: 3 · 2025: 1 · 2024: 6 · 2023: 8 · 2022: 3 · 2021: 9 · 2020: 6 · 2019: 9 · 2018: 8 · 2017: 9 · 2016: 5 · 2015: 7 · 2014: 15 · 2013: 9 · 2012: 9
FWCI: 2.16
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: other-oa
Locations: American Journal of Epidemiology (publishedVersion)
PubMed (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
Bristol Research (University of Bristol) (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
UCL Discovery (University College London) (submittedVersion)
Funders: Bristol-Myers Squibb
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords: Alzheimer's disease, angiotensin-converting enzyme, ACE I/D polymorphism, APOE ε4, genetic susceptibility, genetic association, linkage disequilibrium, heterosis, ethnic differences, Hardy-Weinberg equilibrium, risk factors
MeSH terms: Aged, Alzheimer Disease, Apolipoproteins E, Ethnicity, Female, Humans, Hybrid Vigor, Peptidyl-Dipeptidase A, Male, Middle Aged, Polymorphism, Genetic, Confidence Intervals, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Large Meta-Analysis Establishes the ACE Insertion-Deletion Polymorphism as a Marker of Alzheimer's Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks